FDA Halts Elevidys Shipments - Search News

Order byBest matchMost fresh

News

Elevidys, FDA and Sarepta

· 10d · on MSN

Sarepta to continue Elevidys shipments despite FDA request to halt

Sarepta (SRPT) plans to continue Elevidys shipments for Duchenne muscular dystrophy, despite FDA request not to do so after patient deaths. Read more here.

Continue reading

pharmaphorum · 7h

FDA gives the go-ahead to restart Elevidys shipments

Sarepta Therapeutics to Lift Pause on Shipments of Duchenne Treatment Elevidys

Fierce Pharma21h

FDA takes U-turn on Sarepta’s Elevidys, backing Duchenne gene therapy again in ambulatory patients

On Monday, the FDA said Sarepta may resume treating ambulatory Duchenne patients with Elevidys. The recommendation comes just ...

19hon MSN

Sarepta resumes shipping of gene therapy Elevidys to patients who can walk

Sarepta Therapeutics said on Monday it will resume shipping of its gene therapy Elevidys to patients with a rare muscular ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results